Will Camnitz, MD
Clinical Cardiac Electrophysiology · High Point, NCNPI 1871751545
Payments from drug & device makers
Across 251 payments — averaging $42.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$6K
- Biosense Webster, Inc.$770
- Novartis$562
- Pfizer$558
- Sanofi-aventis U.S. LLC$423
- Boston Scientific$400
- plus $2K from 24 others
What the payments were for
- Speaking & faculty fees$2,50023%
- Travel & lodging$1,16711%
- Food & beverage$7,11766%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 43 | $5,710 |
| Biosense Webster, Inc. | 15 | $770 |
| Novartis | 33 | $562 |
| Pfizer | 30 | $558 |
| Sanofi-aventis U.S. LLC | 13 | $423 |
| Boston Scientific | 8 | $400 |
| Amgen | 21 | $360 |
| Abbott | 15 | $315 |
| Atricure, Inc. | 4 | $271 |
| Biotronik Inc. | 10 | $195 |
| E.r. Squibb & Sons, L.L.C. | 12 | $162 |
| Cvrx, Inc. | 3 | $152 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $141 |
| Johnson & Johnson | 6 | $121 |
| Impulse Dynamics (USA) Inc. | 2 | $105 |
| Philips North America LLC | 4 | $93 |
| Boehringer Ingelheim | 5 | $93 |
| Irhythm Technologies, Inc. | 3 | $83 |
| Cardiva Medical, Inc. | 2 | $45 |
| Bayer | 2 | $40 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $32 |
| Elutia, Inc. | 1 | $24 |
| Portola Pharmaceuticals, LLC | 1 | $23 |
| Edwards Lifesciences | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $15 |
| AstraZeneca | 1 | $15 |
| Cardiovascular Systems Inc. | 1 | $15 |
| Altathera Pharmaceuticals LLC | 1 | $14 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$504
- Claria MRI$326
- AURORA EV-ICD MRI SURESCAN$166
- Reveal LINQ$140
- Rhythmia Mapping System$131
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$130
- DISEASE STATE$125
- MyCareLink Smart$109
- Barostim Neo System$104
How this compares
$10,785 in reported general payments places this provider in the 20th percentile of 98 clinical cardiac electrophysiology providers in North Carolina.
See all clinical cardiac electrophysiology providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 1,072 | $982,153 |
| XareltoRivaroxaban | 274 | $256,824 |
| EntrestoSacubitril/Valsartan | 55 | $66,546 |
| MultaqDronedarone Hcl | 27 | $48,057 |
| Repatha SureclickEvolocumab | 37 | $42,526 |
| Dofetilide | 160 | $27,232 |
| Mexiletine Hcl | 131 | $15,889 |
| Flecainide Acetate | 347 | $12,727 |
| Metoprolol Succinate | 591 | $9,216 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 271 | $8,437 |
| Amiodarone Hcl | 287 | $5,643 |
| Propafenone Hcl ErPropafenone Hcl | 12 | $2,730 |
| Diltiazem 24hr ErDiltiazem Hcl | 30 | $1,885 |
| Losartan Potassium | 99 | $1,648 |
| Potassium Chloride | 73 | $1,599 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $558 | $982,1531,072 claims |
| Johnson & JohnsonXarelto | $121 | $256,824274 claims |
| NovartisEntresto | $562 | $66,54655 claims |
| Sanofi-aventis U.S. LLCMultaq | $423 | $48,05727 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 20th percentile of 98 clinical cardiac electrophysiology providers in North Carolina.
Other clinical cardiac electrophysiology in High Point
- Patrick HranitzkyHigh Point$239K
- Daniel FriedmanDurham$2.3M
- James AllredGreensboro$1.9M
- William SmithWilmington$1.7M
- Marc SilverRaleigh$549K
- Sidharth ShahRaleigh$517K
- Prashant BhaveWinston Salem$348K
- John RhynerAsheville$332K
- Michael DruckerWinston Salem$294K
- Craig McCotterWilmington$294K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.